Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis

Abbas Jafari, Diyako Qanie, Thomas L. Andersen, Yuxi Zhang, Li Chen, Benno Postert, Stuart Parsons, Nicholas Ditzel, Sundeep Khosla, Harald Thidemann Johansen, Per Kjærsgaard-Andersen, Jean Marie Delaisse, Basem M. Abdallah, Daniel Hesselson, Rigmor Solberg, Moustapha Kassem

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Secreted factors are a key component of stem cell niche and their dysregulation compromises stem cell function. Legumain is a secreted cysteine protease involved in diverse biological processes. Here, we demonstrate that legumain regulates lineage commitment of human bone marrow stromal cells and that its expression level and cellular localization are altered in postmenopausal osteoporotic patients. As shown by genetic and pharmacological manipulation, legumain inhibited osteoblast (OB) differentiation and in vivo bone formation through degradation of the bone matrix protein fibronectin. In addition, genetic ablation or pharmacological inhibition of legumain activity led to precocious OB differentiation and increased vertebral mineralization in zebrafish. Finally, we show that localized increased expression of legumain in bone marrow adipocytes was inversely correlated with adjacent trabecular bone mass in a cohort of patients with postmenopausal osteoporosis. Our data suggest that altered proteolytic activity of legumain in the bone microenvironment contributes to decreased bone mass in postmenopausal osteoporosis.

Original languageEnglish (US)
Pages (from-to)373-386
Number of pages14
JournalStem Cell Reports
Volume8
Issue number2
DOIs
StatePublished - Feb 14 2017

Fingerprint

asparaginylendopeptidase
Postmenopausal Osteoporosis
Mesenchymal Stromal Cells
Bone
Osteoblasts
Stem cells
Pharmacology
Stem Cell Niche
Biological Phenomena
Bone and Bones
Bone Matrix
Cysteine Proteases
Zebrafish
Fibronectins
Adipocytes
Osteogenesis
Ablation
Stem Cells
Bone Marrow

Keywords

  • adipocyte
  • bone marrow stromal cells
  • differentiation
  • extracellular matrix
  • fibronectin
  • legumain
  • mesenchymal stem cell
  • osteoblast
  • osteoporosis
  • proliferation

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis. / Jafari, Abbas; Qanie, Diyako; Andersen, Thomas L.; Zhang, Yuxi; Chen, Li; Postert, Benno; Parsons, Stuart; Ditzel, Nicholas; Khosla, Sundeep; Johansen, Harald Thidemann; Kjærsgaard-Andersen, Per; Delaisse, Jean Marie; Abdallah, Basem M.; Hesselson, Daniel; Solberg, Rigmor; Kassem, Moustapha.

In: Stem Cell Reports, Vol. 8, No. 2, 14.02.2017, p. 373-386.

Research output: Contribution to journalArticle

Jafari, A, Qanie, D, Andersen, TL, Zhang, Y, Chen, L, Postert, B, Parsons, S, Ditzel, N, Khosla, S, Johansen, HT, Kjærsgaard-Andersen, P, Delaisse, JM, Abdallah, BM, Hesselson, D, Solberg, R & Kassem, M 2017, 'Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis', Stem Cell Reports, vol. 8, no. 2, pp. 373-386. https://doi.org/10.1016/j.stemcr.2017.01.003
Jafari, Abbas ; Qanie, Diyako ; Andersen, Thomas L. ; Zhang, Yuxi ; Chen, Li ; Postert, Benno ; Parsons, Stuart ; Ditzel, Nicholas ; Khosla, Sundeep ; Johansen, Harald Thidemann ; Kjærsgaard-Andersen, Per ; Delaisse, Jean Marie ; Abdallah, Basem M. ; Hesselson, Daniel ; Solberg, Rigmor ; Kassem, Moustapha. / Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis. In: Stem Cell Reports. 2017 ; Vol. 8, No. 2. pp. 373-386.
@article{06dfc0b7aef841d587b7fbebc30edb32,
title = "Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis",
abstract = "Secreted factors are a key component of stem cell niche and their dysregulation compromises stem cell function. Legumain is a secreted cysteine protease involved in diverse biological processes. Here, we demonstrate that legumain regulates lineage commitment of human bone marrow stromal cells and that its expression level and cellular localization are altered in postmenopausal osteoporotic patients. As shown by genetic and pharmacological manipulation, legumain inhibited osteoblast (OB) differentiation and in vivo bone formation through degradation of the bone matrix protein fibronectin. In addition, genetic ablation or pharmacological inhibition of legumain activity led to precocious OB differentiation and increased vertebral mineralization in zebrafish. Finally, we show that localized increased expression of legumain in bone marrow adipocytes was inversely correlated with adjacent trabecular bone mass in a cohort of patients with postmenopausal osteoporosis. Our data suggest that altered proteolytic activity of legumain in the bone microenvironment contributes to decreased bone mass in postmenopausal osteoporosis.",
keywords = "adipocyte, bone marrow stromal cells, differentiation, extracellular matrix, fibronectin, legumain, mesenchymal stem cell, osteoblast, osteoporosis, proliferation",
author = "Abbas Jafari and Diyako Qanie and Andersen, {Thomas L.} and Yuxi Zhang and Li Chen and Benno Postert and Stuart Parsons and Nicholas Ditzel and Sundeep Khosla and Johansen, {Harald Thidemann} and Per Kj{\ae}rsgaard-Andersen and Delaisse, {Jean Marie} and Abdallah, {Basem M.} and Daniel Hesselson and Rigmor Solberg and Moustapha Kassem",
year = "2017",
month = "2",
day = "14",
doi = "10.1016/j.stemcr.2017.01.003",
language = "English (US)",
volume = "8",
pages = "373--386",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis

AU - Jafari, Abbas

AU - Qanie, Diyako

AU - Andersen, Thomas L.

AU - Zhang, Yuxi

AU - Chen, Li

AU - Postert, Benno

AU - Parsons, Stuart

AU - Ditzel, Nicholas

AU - Khosla, Sundeep

AU - Johansen, Harald Thidemann

AU - Kjærsgaard-Andersen, Per

AU - Delaisse, Jean Marie

AU - Abdallah, Basem M.

AU - Hesselson, Daniel

AU - Solberg, Rigmor

AU - Kassem, Moustapha

PY - 2017/2/14

Y1 - 2017/2/14

N2 - Secreted factors are a key component of stem cell niche and their dysregulation compromises stem cell function. Legumain is a secreted cysteine protease involved in diverse biological processes. Here, we demonstrate that legumain regulates lineage commitment of human bone marrow stromal cells and that its expression level and cellular localization are altered in postmenopausal osteoporotic patients. As shown by genetic and pharmacological manipulation, legumain inhibited osteoblast (OB) differentiation and in vivo bone formation through degradation of the bone matrix protein fibronectin. In addition, genetic ablation or pharmacological inhibition of legumain activity led to precocious OB differentiation and increased vertebral mineralization in zebrafish. Finally, we show that localized increased expression of legumain in bone marrow adipocytes was inversely correlated with adjacent trabecular bone mass in a cohort of patients with postmenopausal osteoporosis. Our data suggest that altered proteolytic activity of legumain in the bone microenvironment contributes to decreased bone mass in postmenopausal osteoporosis.

AB - Secreted factors are a key component of stem cell niche and their dysregulation compromises stem cell function. Legumain is a secreted cysteine protease involved in diverse biological processes. Here, we demonstrate that legumain regulates lineage commitment of human bone marrow stromal cells and that its expression level and cellular localization are altered in postmenopausal osteoporotic patients. As shown by genetic and pharmacological manipulation, legumain inhibited osteoblast (OB) differentiation and in vivo bone formation through degradation of the bone matrix protein fibronectin. In addition, genetic ablation or pharmacological inhibition of legumain activity led to precocious OB differentiation and increased vertebral mineralization in zebrafish. Finally, we show that localized increased expression of legumain in bone marrow adipocytes was inversely correlated with adjacent trabecular bone mass in a cohort of patients with postmenopausal osteoporosis. Our data suggest that altered proteolytic activity of legumain in the bone microenvironment contributes to decreased bone mass in postmenopausal osteoporosis.

KW - adipocyte

KW - bone marrow stromal cells

KW - differentiation

KW - extracellular matrix

KW - fibronectin

KW - legumain

KW - mesenchymal stem cell

KW - osteoblast

KW - osteoporosis

KW - proliferation

UR - http://www.scopus.com/inward/record.url?scp=85011309742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011309742&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2017.01.003

DO - 10.1016/j.stemcr.2017.01.003

M3 - Article

C2 - 28162997

AN - SCOPUS:85011309742

VL - 8

SP - 373

EP - 386

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 2

ER -